We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)
We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Brain Imaging Techniques That Predict Antidepressant Responsiveness
Updated: 12/31/1969
Non-Invasive Brain Imaging Techniques That Predict Antidepressant Responsiveness and Provide Insights Into the Mechanism of Action of Venlafaxine ER vs. Fluoxetine
Status: Enrolling
Updated: 12/31/1969
Brain Imaging Techniques That Predict Antidepressant Responsiveness
Updated: 12/31/1969
Non-Invasive Brain Imaging Techniques That Predict Antidepressant Responsiveness and Provide Insights Into the Mechanism of Action of Venlafaxine ER vs. Fluoxetine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stress Management and Resiliency Training (SMART) Integrated Into Treatment of Major Depression
Updated: 12/31/1969
Stress Management and Resiliency Training (SMART) Integrated Into Comprehensive Treatment of Major Depression: A Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Stress Management and Resiliency Training (SMART) Integrated Into Treatment of Major Depression
Updated: 12/31/1969
Stress Management and Resiliency Training (SMART) Integrated Into Comprehensive Treatment of Major Depression: A Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Updated: 12/31/1969
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Updated: 12/31/1969
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Updated: 12/31/1969
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Updated: 12/31/1969
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Updated: 12/31/1969
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Updated: 12/31/1969
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Updated: 12/31/1969
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Updated: 12/31/1969
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Computerized Cognitive Behavior Therapy in Treating Depression in Patients With Cancer
Updated: 12/31/1969
A Computerized Cognitive Behavioral Therapy for Cancer Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Computerized Cognitive Behavior Therapy in Treating Depression in Patients With Cancer
Updated: 12/31/1969
A Computerized Cognitive Behavioral Therapy for Cancer Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study in Patients With Major Depressive Disorder
Updated: 12/31/1969
A Phase 2a Study to Evaluate the Safety, Tolerability and Initial Efficacy of Pramipexole IR, Given With Ondansetron in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
A Study in Patients With Major Depressive Disorder
Updated: 12/31/1969
A Phase 2a Study to Evaluate the Safety, Tolerability and Initial Efficacy of Pramipexole IR, Given With Ondansetron in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline
Updated: 12/31/1969
LY2216684 and Sertraline Pharmacokinetic Interaction Study in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline
Updated: 12/31/1969
LY2216684 and Sertraline Pharmacokinetic Interaction Study in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2216684 and Warfarin in Healthy Subjects
Updated: 12/31/1969
Effect of LY2216684 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of LY2216684 and Warfarin in Healthy Subjects
Updated: 12/31/1969
Effect of LY2216684 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects
Updated: 12/31/1969
Effect of Activated Charcoal on the Pharmacokinetics of LY2216684 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects
Updated: 12/31/1969
Effect of Activated Charcoal on the Pharmacokinetics of LY2216684 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Evaluate the Effect of Clarithromycin on LY2216684
Updated: 12/31/1969
Effect of Clarithromycin on the Pharmacokinetics of LY2216684 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study to Evaluate the Effect of Clarithromycin on LY2216684
Updated: 12/31/1969
Effect of Clarithromycin on the Pharmacokinetics of LY2216684 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.
Updated: 12/31/1969
LY2216684 and Fluoxetine Pharmacokinetic Interaction Study in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.
Updated: 12/31/1969
LY2216684 and Fluoxetine Pharmacokinetic Interaction Study in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol
Updated: 12/31/1969
Effect of LY2216684 on Heart Rate and Blood Pressure in Healthy Subjects Receiving Oral Doses of Albuterol or Propranolol
Status: Enrolling
Updated: 12/31/1969
A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol
Updated: 12/31/1969
Effect of LY2216684 on Heart Rate and Blood Pressure in Healthy Subjects Receiving Oral Doses of Albuterol or Propranolol
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2216684 and Digoxin in Healthy Subjects
Updated: 12/31/1969
Effect of LY2216684 on the Pharmacokinetics of Digoxin in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of LY2216684 and Digoxin in Healthy Subjects
Updated: 12/31/1969
Effect of LY2216684 on the Pharmacokinetics of Digoxin in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
Updated: 12/31/1969
Effect of LY2216684 on Ambulatory Heart Rate and Blood Pressure in Patients With Major Depressive Disorder Who Are Being Treated With Selective Serotonin Reuptake Inhibitors
Status: Enrolling
Updated: 12/31/1969
A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
Updated: 12/31/1969
Effect of LY2216684 on Ambulatory Heart Rate and Blood Pressure in Patients With Major Depressive Disorder Who Are Being Treated With Selective Serotonin Reuptake Inhibitors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
Updated: 12/31/1969
Effect of LY2216684 on Ambulatory Heart Rate and Blood Pressure in Patients With Major Depressive Disorder Who Are Being Treated With Selective Serotonin Reuptake Inhibitors
Status: Enrolling
Updated: 12/31/1969
A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
Updated: 12/31/1969
Effect of LY2216684 on Ambulatory Heart Rate and Blood Pressure in Patients With Major Depressive Disorder Who Are Being Treated With Selective Serotonin Reuptake Inhibitors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2216684 in Healthy Females
Updated: 12/31/1969
Effect of LY2216684 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of LY2216684 in Healthy Females
Updated: 12/31/1969
Effect of LY2216684 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY03005 vs Pristiq
Updated: 12/31/1969
A Randomized, Open-Label, 2-Treatment, 2-Sequence, 2-Period Crossover Trial to Assess the Bioequivalence of 80 mg LY03005 to 50 mg Pristiq After Single Dose Administration Under Fasting Conditions to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of LY03005 vs Pristiq
Updated: 12/31/1969
A Randomized, Open-Label, 2-Treatment, 2-Sequence, 2-Period Crossover Trial to Assess the Bioequivalence of 80 mg LY03005 to 50 mg Pristiq After Single Dose Administration Under Fasting Conditions to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Evaluate the Effect of Food on LY2216684
Updated: 12/31/1969
Effect of Food on the Pharmacokinetics of LY2216684 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study to Evaluate the Effect of Food on LY2216684
Updated: 12/31/1969
Effect of Food on the Pharmacokinetics of LY2216684 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Mood Internet Intervention Research Project
Updated: 12/31/1969
Internet Intervention to Prevent Major Depressive Episodes
Status: Enrolling
Updated: 12/31/1969
Healthy Mood Internet Intervention Research Project
Updated: 12/31/1969
Internet Intervention to Prevent Major Depressive Episodes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression
Updated: 12/31/1969
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and fMRI Studies of Schizophrenia and Depression
Status: Enrolling
Updated: 12/31/1969
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression
Updated: 12/31/1969
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and fMRI Studies of Schizophrenia and Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Electronic-Measurement Based Care for Major Depressive Disorder
Updated: 12/31/1969
Electronic-Measurement Based Care (e-MBC) for Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
Electronic-Measurement Based Care for Major Depressive Disorder
Updated: 12/31/1969
Electronic-Measurement Based Care (e-MBC) for Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials